44 related articles for article (PubMed ID: 9247286)
1. Analysis of T-cell immune response in renal cell carcinoma: polarization to type 1-like differentiation pattern, clonal T-cell expansion and tumor-specific cytotoxicity.
Angevin E; Kremer F; Gaudin C; Hercend T; Triebel F
Int J Cancer; 1997 Jul; 72(3):431-40. PubMed ID: 9247286
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic and functional analysis of lymphocytes infiltrating paediatric tumours, with a characterization of the tumour phenotype.
Rivoltini L; Arienti F; Orazi A; Cefalo G; Gasparini M; Gambacorti-Passerini C; Fossati-Bellani F; Parmiani G
Cancer Immunol Immunother; 1992; 34(4):241-51. PubMed ID: 1311218
[TBL] [Abstract][Full Text] [Related]
3. Host immune response in renal cell cancer: interleukin-4 (IL-4) and IL-10 mRNA are frequently detected in freshly collected tumor-infiltrating lymphocytes.
Maeurer MJ; Martin DM; Castelli C; Elder E; Leder G; Storkus WJ; Lotze MT
Cancer Immunol Immunother; 1995 Aug; 41(2):111-21. PubMed ID: 7656270
[TBL] [Abstract][Full Text] [Related]
4. Semiquantitative analysis of Th1 and Th2 cytokine expression in CD3+, CD4+, and CD8+ renal-cell-carcinoma-infiltrating lymphocytes.
Elsässer-Beile U; Grussenmeyer T; Gierschner D; Schmoll B; Schultze-Seemann W; Wetterauer U; Schulte Mönting J
Cancer Immunol Immunother; 1999 Jul; 48(4):204-8. PubMed ID: 10431690
[TBL] [Abstract][Full Text] [Related]
5. Analysis of NK cells and chemokine receptors in tumor infiltrating CD4 T lymphocytes in human renal carcinomas.
Cózar JM; Canton J; Tallada M; Concha A; Cabrera T; Garrido F; Ruiz-Cabello Osuna F
Cancer Immunol Immunother; 2005 Sep; 54(9):858-66. PubMed ID: 15887015
[TBL] [Abstract][Full Text] [Related]
6. CD8(+) T lymphocytes isolated from renal cancer patients recognize tumour cells through an HLA- and TCR/CD3-independent pathway.
Lionello I; Mangia P; Gattinoni L; Pende D; Cippone A; Sensi M; Rigatti P; Traversari C
Cancer Immunol Immunother; 2007 Jul; 56(7):1065-76. PubMed ID: 17195078
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterisation of tumour infiltrating lymphocytes in oral squamous cell carcinoma.
Stephens M; Lim K; Stephens P; Thomas DW; Lim SH
Cancer Immunol Immunother; 1998 Mar; 46(1):34-40. PubMed ID: 9520290
[TBL] [Abstract][Full Text] [Related]
8. Expression of aminopeptidase N/CD13 in tumour-infiltrating lymphocytes from human renal cell carcinoma.
Riemann D; Göhring B; Langner J
Immunol Lett; 1994 Sep; 42(1-2):19-23. PubMed ID: 7829125
[TBL] [Abstract][Full Text] [Related]
9. Gamma/delta T cells provide innate immunity against renal cell carcinoma.
Kobayashi H; Tanaka Y; Yagi J; Toma H; Uchiyama T
Cancer Immunol Immunother; 2001 May; 50(3):115-24. PubMed ID: 11419178
[TBL] [Abstract][Full Text] [Related]
10. Tumor-infiltrating CD8
Matsuki M; Hirohashi Y; Nakatsugawa M; Murai A; Kubo T; Hashimoto S; Tokita S; Murata K; Kanaseki T; Tsukahara T; Nishida S; Tanaka T; Kitamura H; Masumori N; Torigoe T
Cancer Immunol Immunother; 2022 Apr; 71(4):905-918. PubMed ID: 34491407
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome following checkpoint therapy in renal cell carcinoma is associated with a burst of activated CD8 T cells in blood.
Carlisle JW; Jansen CS; Cardenas MA; Sobierajska E; Reyes AM; Greenwald R; Del Balzo L; Prokhnevska N; Kucuk O; Carthon BC; Mullane PC; Osunkoya A; Baumgarten D; Hosseinzadeh F; Wilkinson S; Lake R; Sowalsky AG; Liu Y; Master VA; Bilen MA; Kissick H
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35863822
[TBL] [Abstract][Full Text] [Related]
12. Characterization of tumor antigen peptide-specific T cells isolated from the neoplastic tissue of patients with gastric adenocarcinoma.
Amedei A; Niccolai E; Della Bella C; Cianchi F; Trallori G; Benagiano M; Bencini L; Bernini M; Farsi M; Moretti R; Del Prete G; D'Elios MM
Cancer Immunol Immunother; 2009 Nov; 58(11):1819-30. PubMed ID: 19319530
[TBL] [Abstract][Full Text] [Related]
13. LAG-3 as a Potent Target for Novel Anticancer Therapies of a Wide Range of Tumors.
Sauer N; Szlasa W; Jonderko L; Oślizło M; Kunachowicz D; Kulbacka J; Karłowicz-Bodalska K
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077354
[TBL] [Abstract][Full Text] [Related]
14. The immunology of renal cell carcinoma.
Díaz-Montero CM; Rini BI; Finke JH
Nat Rev Nephrol; 2020 Dec; 16(12):721-735. PubMed ID: 32733094
[TBL] [Abstract][Full Text] [Related]
15. On the Other Side: Manipulating the Immune Checkpoint Landscape of Dendritic Cells to Enhance Cancer Immunotherapy.
Kong BY; Bolton H; Kim JW; Silveira PA; Fromm PD; Clark GJ
Front Oncol; 2019; 9():50. PubMed ID: 30788290
[TBL] [Abstract][Full Text] [Related]
16. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.
Hendry S; Salgado R; Gevaert T; Russell PA; John T; Thapa B; Christie M; van de Vijver K; Estrada MV; Gonzalez-Ericsson PI; Sanders M; Solomon B; Solinas C; Van den Eynden GGGM; Allory Y; Preusser M; Hainfellner J; Pruneri G; Vingiani A; Demaria S; Symmans F; Nuciforo P; Comerma L; Thompson EA; Lakhani S; Kim SR; Schnitt S; Colpaert C; Sotiriou C; Scherer SJ; Ignatiadis M; Badve S; Pierce RH; Viale G; Sirtaine N; Penault-Llorca F; Sugie T; Fineberg S; Paik S; Srinivasan A; Richardson A; Wang Y; Chmielik E; Brock J; Johnson DB; Balko J; Wienert S; Bossuyt V; Michiels S; Ternes N; Burchardi N; Luen SJ; Savas P; Klauschen F; Watson PH; Nelson BH; Criscitiello C; O'Toole S; Larsimont D; de Wind R; Curigliano G; André F; Lacroix-Triki M; van de Vijver M; Rojo F; Floris G; Bedri S; Sparano J; Rimm D; Nielsen T; Kos Z; Hewitt S; Singh B; Farshid G; Loibl S; Allison KH; Tung N; Adams S; Willard-Gallo K; Horlings HM; Gandhi L; Moreira A; Hirsch F; Dieci MV; Urbanowicz M; Brcic I; Korski K; Gaire F; Koeppen H; Lo A; Giltnane J; Rebelatto MC; Steele KE; Zha J; Emancipator K; Juco JW; Denkert C; Reis-Filho J; Loi S; Fox SB
Adv Anat Pathol; 2017 Nov; 24(6):311-335. PubMed ID: 28777143
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Infiltrating CD8+ Lymphocytes Effect on Clinical Outcome of Muco-Cutaneous Melanoma.
Rahbar M; Naraghi ZS; Mardanpour M; Mardanpour N
Indian J Dermatol; 2015; 60(2):212. PubMed ID: 25814732
[TBL] [Abstract][Full Text] [Related]
18. Clonal expansion of renal cell carcinoma-infiltrating T lymphocytes.
Sittig SP; Køllgaard T; Grønbæk K; Idorn M; Hennenlotter J; Stenzl A; Gouttefangeas C; Thor Straten P
Oncoimmunology; 2013 Sep; 2(9):e26014. PubMed ID: 24228230
[TBL] [Abstract][Full Text] [Related]
19. Neem leaf glycoprotein activates CD8(+) T cells to promote therapeutic anti-tumor immunity inhibiting the growth of mouse sarcoma.
Mallick A; Barik S; Goswami KK; Banerjee S; Ghosh S; Sarkar K; Bose A; Baral R
PLoS One; 2013; 8(1):e47434. PubMed ID: 23326300
[TBL] [Abstract][Full Text] [Related]
20. Effector CD4 and CD8 T cells and their role in the tumor microenvironment.
Hadrup S; Donia M; Thor Straten P
Cancer Microenviron; 2013 Aug; 6(2):123-33. PubMed ID: 23242673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
